Chasing the Paradigm: Clinical Translation of 25 Years of Tissue Engineering

Tissue Eng Part A. 2019 May;25(9-10):679-687. doi: 10.1089/ten.TEA.2019.0032.

Abstract

In this Perspective, we discuss the impact of the past 25 years of tissue engineering on the development of clinical therapies. Based on their success and other significant research accomplishments, platforms of innovation were identified. Their discoveries will enable tissue engineering inspired therapies to meet the requirements necessary for large-scale manufacturing and Food and Drug Administration (FDA) approval for a diverse range of indications.

Keywords: 3D bioprinting; clinical; personalized medicine; regenerative medicine; tissue engineering.

Publication types

  • Historical Article
  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Review

MeSH terms

  • Bioprinting / history*
  • History, 20th Century
  • History, 21st Century
  • Humans
  • Printing, Three-Dimensional / history*
  • Regenerative Medicine / history*
  • Tissue Engineering / history*
  • Tissue Scaffolds*